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This Article contains errors.

Affiliation 6 was incorrectly listed as 'Department of Chemistry and Applied Biosciences, ETH Zurich, 8092 Zurich, Switzerland'. The correct affiliation is listed below:

Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.

In the Results section under subheading 'Longitudinal in vivo assessment of biomaterial-induced bone formation'

"Over the following 8 weeks the plural stayed closed".

should read:

"Over the following 8 weeks the defects stayed closed"

Under subheading 'Temporal and spatial in vivo assessment of hydroxyapatite deposition during bone defect regeneration -- anterior-posterior axis.'

"Thereafter no significant SPECT signal as well as no increase in bone volume was observed. In contrast, the BMP-2 hydrogel samples induced a comparably stronger signal on the anterior side of the defect and already an observable signal inside the bone defect (Fig. 4B)."

should read:

"No significant SPECT signal as well as no increase in bone volume were observed thereafter. In contrast, after 1 week of treatment BMP-2 hydrogel samples induced a comparably stronger signal on the anterior side of the defect and already an observable signal inside the bone defect (Fig. 4B)."

In the Discussion section

"The used pinhole technology compared to the clinical applied parallel hole collimators allows to achieve a higher resolution at the expense of sensitivity."

"should read:"

"In comparison to the clinically applied parallel hole collimators the herein used pinhole technology allows to achieve a higher resolution at the expense of sensitivity."

In addition, the Acknowledgements section,
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should read:
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